Cryssi Soins: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Cryssi Soins
Largest movements
- Cash +€34,584
up €34,584 (+110%), from €31,388 to €65,972
mainly Receivables within one year (+€17,039) and Net result for the year (+€16,626)
- Receivables within one year -€17,039
down €17,039 (-51.6%), from €33,012 to €15,973
of which Other amounts receivable: -€18,771
- Profit (loss) carried forward +€16,626
up €16,626 (+26.9%), from €61,707 to €78,333
- Gross operating margin +€9,662
up €9,662 (+55.4%), from €17,436 to €27,099
- Taxes +€3,981
up €3,981 (+70.6%), from €5,640 to €9,621
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €67,912 | €84,335 | +€16,423 | +24.2% |
| Fixed assets | 21/28 | €2,731 | €2,094 | -€637 | -23.3% |
| Tangible fixed assets | 22/27 | €2,731 | €2,094 | -€637 | -23.3% |
| Plant, machinery and equipment | 23 | €2,731 | €2,094 | -€637 | -23.3% |
| Current assets | 29/58 | €65,181 | €82,241 | +€17,060 | +26.2% |
| Amounts receivable within one year | 40/41 | €33,012 | €15,973 | -€17,039 | -51.6% |
| Trade receivables | 40 | €8,208 | €9,940 | +€1,732 | +21.1% |
| Other amounts receivable | 41 | €24,804 | €6,033 | -€18,771 | -75.7% |
| Cash at bank and in hand | 54/58 | €31,388 | €65,972 | +€34,584 | +110% |
| Deferred charges and accrued income | 490/1 | €782 | €297 | -€485 | -62.1% |
| Total equity and liabilities | 10/49 | €67,912 | €84,335 | +€16,423 | +24.2% |
| Equity | 10/15 | €67,707 | €84,333 | +€16,626 | +24.6% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Capital | 10 | €5,000 | €5,000 | = | 0.0% |
| Issued capital | 100 | €10,000 | €10,000 | = | 0.0% |
| Uncalled capital | 101 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €1,000 | €1,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,000 | €1,000 | = | 0.0% |
| Legal reserve | 130 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €61,707 | €78,333 | +€16,626 | +26.9% |
| Amounts payable | 17/49 | €205 | €3 | -€202 | -98.5% |
| Amounts payable within one year | 42/48 | €205 | €3 | -€202 | -98.5% |
| Financial debts | 43 | €3 | €3 | = | 0.0% |
| Credit institutions | 430/8 | €3 | €3 | = | 0.0% |
| Trade debts | 44 | €202 | - | -€202 | |
| Suppliers | 440/4 | €202 | - | -€202 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €435 | €637 | +€201 | +46.3% |
| Other operating charges | 640/8 | €205 | €176 | -€29 | -14.2% |
| Gross operating margin | 9900 | €17,436 | €27,099 | +€9,662 | +55.4% |
| Operating profit (loss) | 9901 | €16,797 | €26,287 | +€9,490 | +56.5% |
| Financial income | 75/76B | €0 | €9 | +€9 | +42,700% |
| Recurring financial income | 75 | €0 | €9 | +€9 | +42,700% |
| Financial charges | 65/66B | €61 | €48 | -€13 | -21.4% |
| Recurring financial charges | 65 | €61 | €48 | -€13 | -21.4% |
| Profit (loss) for the period before taxes | 9903 | €16,735 | €26,247 | +€9,512 | +56.8% |
| Income taxes | 67/77 | €5,640 | €9,621 | +€3,981 | +70.6% |
| Profit (loss) for the period | 9904 | €11,095 | €16,626 | +€5,530 | +49.8% |
| Profit (loss) for the period to be appropriated | 9905 | €11,095 | €16,626 | +€5,530 | +49.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.